Trial intelligence / Profile preview

Hypercaloric nutrition and testosterone undecanoate in severe COPD

2005-004291-20Phase 3Completed

Sponsor: Prof. Dr. Hartmut Zwick
Start: Apr 2006
Countries: 1

Overview

Phase 3 trial of testosterone undecanoate in chronic obstructive pulmonary disease (COPD), sponsored by Prof. Dr. Hartmut Zwick. Primary endpoint: Change in quadriceps femoris muscle strength. Started Apr 2006; status: completed.

Drugs

testosterone undecanoate

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on 2005-004291-20.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-004291-20.